VRRM vs. MODV, SPCE, EXPE, XPO, MMYT, GXO, GATX, HAFN, GBTG, and RXO
Should you be buying Verra Mobility stock or one of its competitors? The main competitors of Verra Mobility include ModivCare (MODV), Virgin Galactic (SPCE), Expedia Group (EXPE), XPO (XPO), MakeMyTrip (MMYT), GXO Logistics (GXO), GATX (GATX), Hafnia (HAFN), Global Business Travel Group (GBTG), and RXO (RXO). These companies are all part of the "transportation services" industry.
ModivCare (NASDAQ:MODV) and Verra Mobility (NASDAQ:VRRM) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, risk, earnings, profitability, analyst recommendations, dividends, valuation, community ranking and media sentiment.
Verra Mobility has lower revenue, but higher earnings than ModivCare. ModivCare is trading at a lower price-to-earnings ratio than Verra Mobility, indicating that it is currently the more affordable of the two stocks.
In the previous week, Verra Mobility had 3 more articles in the media than ModivCare. MarketBeat recorded 5 mentions for Verra Mobility and 2 mentions for ModivCare. ModivCare's average media sentiment score of 1.35 beat Verra Mobility's score of 0.87 indicating that Verra Mobility is being referred to more favorably in the news media.
ModivCare has a beta of 0.41, suggesting that its share price is 59% less volatile than the S&P 500. Comparatively, Verra Mobility has a beta of 1.16, suggesting that its share price is 16% more volatile than the S&P 500.
Verra Mobility has a net margin of 9.77% compared to Verra Mobility's net margin of -8.02%. ModivCare's return on equity of 37.87% beat Verra Mobility's return on equity.
Verra Mobility received 52 more outperform votes than ModivCare when rated by MarketBeat users. Likewise, 50.38% of users gave Verra Mobility an outperform vote while only 40.00% of users gave ModivCare an outperform vote.
ModivCare presently has a consensus target price of $49.25, suggesting a potential upside of 80.27%. Verra Mobility has a consensus target price of $22.33, suggesting a potential downside of 16.17%. Given Verra Mobility's higher probable upside, research analysts clearly believe ModivCare is more favorable than Verra Mobility.
Summary
Verra Mobility beats ModivCare on 14 of the 16 factors compared between the two stocks.
Get Verra Mobility News Delivered to You Automatically
Sign up to receive the latest news and ratings for VRRM and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding VRRM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Verra Mobility Competitors List
Related Companies and Tools
